Skip to content
You are not logged in |Login  
     
Limit search to available items
Book Cover
Bestseller
BestsellerE-Book
Author Katz, Martin M., author.

Title Clinical trials of antidepressants : how changing the model can uncover new, more effective molecules / Martin M. Katz.

Publication Info. [Cham] : Springer, 2016.

Copies

Location Call No. Status
 University of Saint Joseph: Pope Pius XII Library - Internet  WORLD WIDE WEB E-BOOK SPRINGER    Downloadable
University of Saint Joseph patrons, please click here to access this SpringerLink resource
Description 1 online resource.
Series SpringerBriefs in psychology
SpringerBriefs in psychology.
Note Online resource; title from PDF title page (EBSCO, viewed February 12, 2016).
Bibliography Includes bibliographical references and index.
Contents Introduction -- Why now the need for a new clinical trials model for antidepressants? -- Reconceptualizing depression, and the current sense on dimensionality and the RDoC -- Aims and basic requirements of clinical trials : conventional and component-specific models -- Methods for measuring the components and profile of drug actions : the multivantaged approach -- Achieving the "ideal" clinical trial : an example of applying the merged componential and established models -- Comparing the component-specific model directly with the established diagnosis-specific trial -- Prediction and shortening the clinical trial : further advantages of the component-specific model -- The video clinical trial -- Conclusions.
Summary This brief guide takes current clinical trial protocols to task and replaces them with a contemporary framework for improving next-generation antidepressants and their underlying science. Innovative models are based on a nuanced, neurologically-informed understanding of drug mechanisms and the component cognitive, mood, and behavioral aspects of depression. The book reconceptualizes not only the clinical trial process but the clinical concept of depression itself as essential to bringing pharmaceutical research and development up to date, boosting efficiency and effectiveness, finding new molecules, and reducing waste. Case studies and a review of salient depression scales illustrate the potential benefits of such wide-scale change. Included in the coverage: Why now the need for a new clinical trials model for antidepressants? Aims and basic requirements of clinical trials: conventional and component-specific models. Methods for measuring the components and the profile of drug actions: the multivantaged approach. Achieving the ideal clinical trial: an example of the merged componential and established models. Prediction and shortening the clinical trial. The video clinical trial. Clinical Trials of Antidepressants will interest a varied audience, including clinical investigators, academic and pharmaceutical company scientists, clinical trial organizations, psychiatrists, outpatient physicians, psychotherapists, clinical psychologists, psychology graduate students, medical students, and government agencies such as the FDA.
Subject Clinical trials -- Statistical methods.
Clinical trials -- Mathematical models.
Antidepressants -- Evaluation.
HEALTH & FITNESS -- Holism.
HEALTH & FITNESS -- Reference.
MEDICAL -- Alternative Medicine.
MEDICAL -- Atlases.
MEDICAL -- Essays.
MEDICAL -- Family & General Practice.
MEDICAL -- Holistic Medicine.
MEDICAL -- Osteopathy.
Genre/Form Electronic books.
ISBN 9783319264646 (electronic bk.)
3319264648 (electronic bk.)
331926463X
9783319264639
9783319264639
-->
Add a Review